Ethics declarations Ethics approval and consent to participate The study was approved by the Ethics Committee of Zhengzhou University Peoples Hospital
Frequently Asked Questions What is the projected industry size of the GLP-1 nutritional support market by 2035
Interestingly, TGF was strongly associated with BBB disruption and structural brain changes
AM: Funding acquisition, Project administration, Supervision, Writingreview and editing
Yes semaglutide (Wegovy) and liraglutide (Saxenda) are licensed GLP-1 receptor agonist medicines available through NHS specialist weight management services for eligible patients, in line with NICE TA875 and NICE TA664 respectively
News provided by 9amHealth Jun 17, 2025, 09:00 ET Collaboration brings low-cost obesity medications plus expert-led, whole-body care to employer benefit plans